Document Detail

Acacia honey and chrysin reduce proliferation of melanoma cells through alterations in cell cycle progression.
MedLine Citation:
PMID:  20811719     Owner:  NLM     Status:  MEDLINE    
Honey has long been used in medicine for different purposes. Only recently, however, its antioxidant property and preventive effects against different diseases, such as cancer, have been highlighted. Chrysin (5,7-dihydroxyflavone) is a natural flavone commonly found in acacia honey. It has previously been shown to be an anti-tumor agent. In this study, we investigated the antiproliferative role of honey or chrysin on human (A375) and murine (B16-F1) melanoma cell lines. The results of the 3-(4,5-Dimethylthiazol-2-yl)-2,5-diphenyl tetrazolium bromide (MTT) assay and the trypan blue exclusion test showed that both the tested compounds were able to induce an antiproliferative effect on melanoma cells in a dose- and time-dependent manner. Flow cytometry analysis indicated that cytotoxicity induced by honey or chrysin was mediated by G(0)/G(1) cell cycle arrest and induction of hyperploid progression. Our results suggest that the anti-proliferative effects of honey are due mainly to the presence of chrysin. Chrysin may therefore be considered a potential candidate for both cancer prevention and treatment. Further investigation is needed to validate the contribution of chrysin in tumor therapy in vivo.
Elena Pichichero; Rosella Cicconi; Maurizio Mattei; Marco Gallinella Muzi; Antonella Canini
Related Documents :
9252669 - Paclitaxel and n-methylformamide: in vitro interactions in human colon cancer cell line.
19888639 - Porphyrin and galactosyl conjugated micelles for targeting photodynamic therapy.
25467039 - Fragmentation of human cleavage-stage embryos is related to the progression through mei...
25261369 - Catalytic mtor inhibitors can overcome intrinsic and acquired resistance to allosteric ...
22447269 - Ultraviolet action spectrum for cell killing of primary porcine lens epithelial cells.
1972659 - Generation of lymphokine-activated killer cell activity by low-dose recombinant interle...
25421149 - Reaction-diffusion finite element model of lateral line primordium migration to explore...
17895839 - Intranuclear rodlets in human pancreatic islet cells.
23689509 - Cop9 signalosome subunit csn8 is involved in maintaining proper duration of the g1 phase.
Publication Detail:
Type:  Journal Article; Research Support, Non-U.S. Gov't    
Journal Detail:
Title:  International journal of oncology     Volume:  37     ISSN:  1791-2423     ISO Abbreviation:  Int. J. Oncol.     Publication Date:  2010 Oct 
Date Detail:
Created Date:  2010-09-02     Completed Date:  2010-12-23     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  9306042     Medline TA:  Int J Oncol     Country:  Greece    
Other Details:
Languages:  eng     Pagination:  973-81     Citation Subset:  IM    
Department of Biology, Honey Research Center, University of Rome 'Tor Vergata' Via della Ricerca Scientifica 1, I-00133 Rome, Italy.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Antineoplastic Agents / pharmacology*
Cell Cycle / drug effects*
Cell Line, Tumor
Cell Proliferation / drug effects*
Dose-Response Relationship, Drug
Energy Metabolism / drug effects
Flavonoids / pharmacology*
Melanoma / metabolism,  pathology*
Melanoma, Experimental / pathology
Time Factors
Reg. No./Substance:
0/Antineoplastic Agents; 0/Flavonoids; 480-40-0/chrysin

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Enhanced growth inhibition by combined DNA methylation/HDAC inhibitors in lung tumor cells with sile...
Next Document:  Biological effects of induced MYCN hyper-expression in MYCN-amplified neuroblastomas.